Floatz logo

Cyclophosphamide

NK-Cell Lymphoma

New York Medical CollegeSmall moleculePhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the NK-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
Masonic Cancer Center, University of Minnesota
Phase 3BB
CYCLOSPORIN A
Medical College of Wisconsin
Phase 3B
Rapamycin
Masonic Cancer Center, University of Minnesota
Phase 2B
Equine Atg
Masonic Cancer Center, University of Minnesota
Phase 2B
Umbilical Cord Blood Mononuclear Cells
Masonic Cancer Center, University of Minnesota
Phase 2B

View all 26 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →